<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td align="center" stylecode="Lrule Rrule" valign="top"> <br/>
<content stylecode="bold">Drugs That May Increase Serum TBG Concentration</content>
<br/>
</td>
<td align="left" stylecode="Rrule" valign="top">
<content stylecode="bold">Drugs That May Decrease Serum TBG Concentration                                                   </content>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Clofibrate<br/> <br/>Estrogen-containing oral contraceptives<br/>
<br/>Estrogens (oral)<br/>
<br/>Heroin/Methadone<br/>
<br/>5-Fluorouracil<br/>
<br/>Mitotane<br/>
<br/>Tamoxifen<br/>
<br/>
<br/>
</td>
<td align="left" stylecode="Rrule" valign="top"> <br/>Androgens/Anabolic Steroids<br/> <br/>Asparaginase<br/>
<br/>Glucocorticoids<br/>
<br/>Slow-Release Nicotinic Acid<br/>
<br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="left" colspan="2" stylecode="Lrule Rrule" valign="top"> <br/>
<br/>
<content stylecode="bold">Drugs That May Cause Protein-Binding Site Displacement</content> <br/>Potential impact<content stylecode="bold">:</content> Administration of these agents with levothyroxine results in an initial transient increase in FT<sub>4</sub>.  Continued administration results in a decrease in serum T<sub>4</sub> and normal FT<sub>4</sub> and TSH concentrations and, therefore, patients are clinically euthyroid.<br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Salicylates (&gt; 2 g/day)<br/> <br/>
<br/>
</td>
<td align="left" stylecode="Rrule" valign="top"> <br/>Salicylates inhibit binding of T<sub>4</sub> and T<sub>3</sub> to TBG and transthyretin.  An initial increase in serum FT<sub>4</sub> is followed by return of FT<sub>4</sub> to normal levels with sustained therapeutic serum salicylate concentrations, although total-T<sub>4</sub> levels may decrease by as much as 30%.<br/> <br/>
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode="Lrule Rrule" valign="top"> <br/>Other drugs:<br/> <br/>Furosemide (&gt; 80 mg IV)<br/>
<br/>Heparin <br/>
<br/>Hydantoins <br/>
<br/>Non-Steroidal Anti-inflammatory Drugs<br/>
<br/>- Fenamates<br/>
<br/>- Phenylbutazone<br/>
<br/>
<br/>
</td>
<td align="left" stylecode="Rrule" valign="top"> <br/>
</td>
</tr>
</tbody>
</table>